BOSTON (AP) — BOSTON (AP) — Zevra Therapeutics, Inc. (ZVRA) on Tuesday reported third-quarter earnings of $19.2 million.

The Boston-based company said it had net income of 26 cents per share. Earnings, adjusted for non-recurring gains, came to 18 cents per share.

The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 14 cents per share.

The specialty pharmaceutical company posted revenue of $37.8 million in the period, also beating Street forecasts. Three analysts surveyed by Zacks expected $36.7 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ZVRA at https://www.zacks.com/ap/ZVRA